<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="ted/R2.0.8.S03/publication" xmlns:n2016="ted/2016/nuts" xsi:schemaLocation="ted/R2.0.8.S03/publication TED_EXPORT.xsd" DOC_ID="027339-2018" EDITION="2018013"><TECHNICAL_SECTION><RECEPTION_ID>18-025523-001</RECEPTION_ID><DELETION_DATE>20180427</DELETION_DATE><FORM_LG_LIST>PL </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple " xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>13</NO_OJ><DATE_PUB>20180119</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2018/S 013-027339</NO_DOC_OJS><URI_LIST><URI_DOC LG="PL">http://ted.europa.eu/udl?uri=TED:NOTICE:027339-2018:TEXT:PL:HTML</URI_DOC></URI_LIST><LG_ORIG>PL</LG_ORIG><ISO_COUNTRY VALUE="PL"/><IA_URL_GENERAL>www.przetargi.bieganski.org</IA_URL_GENERAL><ORIGINAL_CPV CODE="33652100">Antineoplastic agents</ORIGINAL_CPV><ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV><VALUES_LIST><VALUES TYPE="GLOBAL"><SINGLE_VALUE><VALUE CURRENCY="PLN">1 495 528,24</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">17 710,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">259 259,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">83 891,68</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">92 700,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">73 155,50</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">313 740,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">41 984,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">31 185,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">5 500,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">245 000,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">84 444,36</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">72 616,60</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">942,10</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="PLN">173 400,00</VALUE></SINGLE_VALUE></VALUES></VALUES_LIST><REF_NOTICE><NO_DOC_OJS>2017/S 195-401677</NO_DOC_OJS></REF_NOTICE></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20180117</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="1">Open procedure</PR_PROC><RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01203</HEADING><DIRECTIVE VALUE="2004/18/EC"/></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Полша</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Антинеопластични средства</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Polsko</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antineoplastika</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Polen</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Cytostatika</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Polen</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antineoplastische Mittel</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Πολωνία</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Αντινεοπλασματικά φάρμακα</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Poland</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antineoplastic agents</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Polonia</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Agentes antineoplásicos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Poola</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antineoplastilised ained</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Puola</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Solunsalpaajat ja sytostaatit</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Pologne</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antinéoplasiques</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Pholainn, an</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antineoplastic agents</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Poljska</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antineoplastični lijekovi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Lengyelország</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Daganatellenes szerek</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Polonia</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Agenti antineoplastici</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Lenkija</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antinavikiniai vaistai</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Polija</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antineoplastiskie līdzekļi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>il-Polonja</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Aġenti ta' l-antineoplastika</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Polen</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antineoplastische middelen</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Polska</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Środki przeciwnowotworowe</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Polónia</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antineoplásicos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Polonia</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antineoplazice</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Poľsko</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Antineoplastické činidlá</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Poljska</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Zdravila z delovanjem na novotvorbe</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Polen</TI_CY><TI_TOWN>Grudziądz</TI_TOWN><TI_TEXT>Cytostatika/cytotoxiska medel</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="PL">Regionalny Szpital Specjalistyczny im Dr. Władysława Biegańskiego</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><CONTRACT_AWARD CATEGORY="ORIGINAL" FORM="3" LG="PL" VERSION="R2.0.8.S03.E01"><FD_CONTRACT_AWARD CTYPE="SUPPLIES"><CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION><OFFICIALNAME>Regionalny Szpital Specjalistyczny im Dr. Władysława Biegańskiego</OFFICIALNAME></ORGANISATION><ADDRESS>ul. L. Rydygiera 15/17</ADDRESS><TOWN>Grudziądz</TOWN><POSTAL_CODE>86-300</POSTAL_CODE><COUNTRY VALUE="PL"/><ATTENTION>Alina Pieniak, Monika Kubicka</ATTENTION><PHONE>+48 566413465/4650</PHONE><FAX>+48 564621334</FAX></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_CONTRACT_AWARD><URL_GENERAL>www.przetargi.bieganski.org</URL_GENERAL></INTERNET_ADDRESSES_CONTRACT_AWARD></NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY_OTHER VALUE="OTHER">Samodzielny Publiczny Zakład Opieki Zdrowotnej</TYPE_OF_CONTRACTING_AUTHORITY_OTHER><TYPE_OF_ACTIVITY VALUE="HEALTH"/></TYPE_AND_ACTIVITIES><PURCHASING_ON_BEHALF><PURCHASING_ON_BEHALF_NO/></PURCHASING_ON_BEHALF></TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><DESCRIPTION_AWARD_NOTICE_INFORMATION><TITLE_CONTRACT><P>Dostawy leków p/nowotworowych i immunomodulacyjnych</P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION_W_PUB><TYPE_CONTRACT VALUE="SUPPLIES"/><TYPE_SUPPLIES_CONTRACT VALUE="PURCHASE"/></TYPE_CONTRACT_LOCATION_W_PUB><LOCATION_NUTS><LOCATION><P>magazyn apteki szpitalnej ul. Rydygiera 15/17 w Grudziądzu</P></LOCATION></LOCATION_NUTS><SHORT_CONTRACT_DESCRIPTION><P>Przedmiotem zamówienia są dostawy sukcesywne leków p/nowotworowych i immunomodulacyjnych.</P><P>W asortymentach i ilościach podanych w formularzach cenowych stanowiących Załącznik Nr 2, w którym zamawiający określił standardy jakościowe odnoszące się do wszystkich istotnych cech przedmiotu zamówienia.</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652100"/></CPV_MAIN><CPV_ADDITIONAL><CPV_CODE CODE="33600000"/></CPV_ADDITIONAL></CPV><CONTRACT_COVERED_GPA VALUE="YES"/></DESCRIPTION_AWARD_NOTICE_INFORMATION><TOTAL_FINAL_VALUE><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="1495528.24">1 495 528,24</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></TOTAL_FINAL_VALUE></OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><TYPE_OF_PROCEDURE_DEF><PT_OPEN/></TYPE_OF_PROCEDURE_DEF><AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><AWARD_CRITERIA_DETAIL_F03><LOWEST_PRICE/></AWARD_CRITERIA_DETAIL_F03><F03_IS_ELECTRONIC_AUCTION_USABLE VALUE="NO"/></AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD><FILE_REFERENCE_NUMBER><P>A/9/PN/17</P></FILE_REFERENCE_NUMBER><PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3><PREVIOUS_PUBLICATION_EXISTS_F3><CNT_NOTICE_INFORMATION><CNT_NOTICE_INFORMATION_S CHOICE="CONTRACT_NOTICE"/><NOTICE_NUMBER_OJ>2017/S 195-401677</NOTICE_NUMBER_OJ><DATE_OJ><DAY>11</DAY><MONTH>10</MONTH><YEAR>2017</YEAR></DATE_OJ></CNT_NOTICE_INFORMATION><OTHER_PREVIOUS_PUBLICATIONS><OTHER_PREVIOUS_PUBLICATION><NOTICE_NUMBER_OJ>2017/S 223-464765</NOTICE_NUMBER_OJ><DATE_OJ><DAY>21</DAY><MONTH>11</MONTH><YEAR>2017</YEAR></DATE_OJ></OTHER_PREVIOUS_PUBLICATION></OTHER_PREVIOUS_PUBLICATIONS></PREVIOUS_PUBLICATION_EXISTS_F3></PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3></ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD></PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>1</LOT_NUMBER><CONTRACT_TITLE><P>Arixtra</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Aspen Pharma Ireland Limited</OFFICIALNAME></ORGANISATION><ADDRESS>One George’s Quay Plaza</ADDRESS><TOWN>Dublin 2</TOWN><COUNTRY VALUE="IE"/><E_MAILS><E_MAIL>malgorzata.rzegalinska@aspenpharma.eu</E_MAIL></E_MAILS><PHONE>+48 222043208</PHONE><URL>www.aspenpharma.eu</URL><FAX>+48 222043299</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="17710.00">17 710,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><CONTRACT_LIKELY_SUB_CONTRACTED><UNKNOWN_VALUE/></CONTRACT_LIKELY_SUB_CONTRACTED></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>2</LOT_NUMBER><CONTRACT_TITLE><P>Tecfidera</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Konsorcjum firm: PGF Urtica Sp. z o.o.i Polska Grupa Farmaceutyczna S.A.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Krzemieniecka 120</ADDRESS><TOWN>Wrocław</TOWN><POSTAL_CODE>54-613</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>przetargi@urtica.pl</E_MAIL></E_MAILS><PHONE>+48 717826600</PHONE><URL>www.urtica.pl</URL><FAX>+48 717826643</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="259259.00">259 259,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>3</LOT_NUMBER><CONTRACT_TITLE><P>Leki różne</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Konsorcjum firm: PGF Urtica Sp. z o.o.i Polska Grupa Farmaceutyczna S.A.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Krzemieniecka 120</ADDRESS><TOWN>Wrocław</TOWN><POSTAL_CODE>54-613</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>przetargi@urtica.pl</E_MAIL></E_MAILS><PHONE>+48 717826600</PHONE><URL>www.urtica.pl</URL><FAX>+48 717826643</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="83891.68">83 891,68</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>4</LOT_NUMBER><CONTRACT_TITLE><P>Remurel</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>2</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Konsorcjum firm: PGF Urtica Sp. z o.o.i Polska Grupa Farmaceutyczna S.A.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Krzemieniecka 120</ADDRESS><TOWN>Wrocław</TOWN><POSTAL_CODE>54-613</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>przetargi@urtica.pl</E_MAIL></E_MAILS><PHONE>+48 717826600</PHONE><URL>www.urtica.pl</URL><FAX>+48 717826643</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="92700.00">92 700,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>5</LOT_NUMBER><CONTRACT_TITLE><P>Aubagio</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Sanofi- Aventis Sp. z o. o.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Bonifraterska 17</ADDRESS><TOWN>Warszawa</TOWN><POSTAL_CODE>00-203</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>dzial.przetargow@sanofi.com</E_MAIL></E_MAILS><PHONE>+48 222800861</PHONE><URL>www.sanofi.pl</URL><FAX>+48 222800605</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="73155.50">73 155,50</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>6</LOT_NUMBER><CONTRACT_TITLE><P>Lemtrada</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Sanofi- Aventis Sp. z o. o.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Bonifraterska 17</ADDRESS><TOWN>Warszawa</TOWN><POSTAL_CODE>00-203</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>dzial.przetargow@sanofi.com</E_MAIL></E_MAILS><PHONE>+48 222800861</PHONE><URL>www.sanofi.pl</URL><FAX>+48 222800605</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="313740.00">313 740,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>7</LOT_NUMBER><CONTRACT_TITLE><P>Abraxane</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Komtur Polska Sp. z o. o.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Puławska 405A</ADDRESS><TOWN>Warszawa</TOWN><POSTAL_CODE>02-801</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>zp@komtur.com</E_MAIL></E_MAILS><PHONE>+48 225662620</PHONE><URL>www.komtur.pl</URL><FAX>+48 225662607</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="41984.00">41 984,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>8</LOT_NUMBER><CONTRACT_TITLE><P>Calciumfolinat</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Asclepios S. A.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Hubska 44</ADDRESS><TOWN>Wrocław</TOWN><POSTAL_CODE>50-502</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>przetargi@asclepios.pl</E_MAIL></E_MAILS><PHONE>+48 717698410</PHONE><URL>www.asclepios.pl</URL><FAX>+48 717215625</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="31185.00">31 185,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>9</LOT_NUMBER><CONTRACT_TITLE><P>Etoposid</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>2</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Konsorcjum firm: PGF Urtica Sp. z o.o.i Polska Grupa Farmaceutyczna S.A.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Krzemieniecka 120</ADDRESS><TOWN>Wrocław</TOWN><POSTAL_CODE>54-613</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>przetargi@urtica.pl</E_MAIL></E_MAILS><PHONE>+48 717826600</PHONE><URL>www.urtica.pl</URL><FAX>+48 717826643</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="5500.00">5 500,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>10</LOT_NUMBER><CONTRACT_TITLE><P>Herceptin</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>28</DAY><MONTH>12</MONTH><YEAR>2017</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Roche Polska Sp. z o. o.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Domaniewska 39B</ADDRESS><TOWN>Warszawa</TOWN><POSTAL_CODE>02-672</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>pl.przetargi@roche.com</E_MAIL></E_MAILS><PHONE>+48 222605161</PHONE><URL>www.roche.pl</URL><FAX>+48 223451527</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="245000.00">245 000,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>11</LOT_NUMBER><CONTRACT_TITLE><P>Zaltrap</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Sanofi- Aventis Sp. z o. o.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Bonifraterska 17</ADDRESS><TOWN>Warszawa</TOWN><POSTAL_CODE>00-203</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>dzial.przetargow@sanofi.com</E_MAIL></E_MAILS><PHONE>+48 222800861</PHONE><URL>www.sanofi.pl</URL><FAX>+48 222800605</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="84444.36">84 444,36</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>12</LOT_NUMBER><CONTRACT_TITLE><P>Erbitux</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Konsorcjum firm: PGF Urtica Sp. z o.o.i Polska Grupa Farmaceutyczna S.A.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Krzemieniecka 120</ADDRESS><TOWN>Wrocław</TOWN><POSTAL_CODE>54-613</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>przetargi@urtica.pl</E_MAIL></E_MAILS><PHONE>+48 717826600</PHONE><URL>www.urtica.pl</URL><FAX>+48 717826643</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="72616.60">72 616,60</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>13</LOT_NUMBER><CONTRACT_TITLE><P>Akynzeo</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Asclepios S. A.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Hubska 44</ADDRESS><TOWN>Wrocław</TOWN><POSTAL_CODE>50-502</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>przetargi@asclepios.pl</E_MAIL></E_MAILS><PHONE>+48 717698410</PHONE><URL>www.asclepios.pl</URL><FAX>+48 717215625</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="942.10">942,10</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><AWARD_OF_CONTRACT><CONTRACT_NUMBER>Dostawy leków p/nowotworowych i immunomodulacyjnych</CONTRACT_NUMBER><LOT_NUMBER>14</LOT_NUMBER><CONTRACT_TITLE><P>Perjeta</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>28</DAY><MONTH>12</MONTH><YEAR>2017</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>0</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Roche Polska Sp. z o. o.</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Domaniewska 39B</ADDRESS><TOWN>Warszawa</TOWN><POSTAL_CODE>02-672</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>pl.przetargi@roche.com</E_MAIL></E_MAILS><PHONE>+48 222605161</PHONE><URL>www.roche.pl</URL><FAX>+48 223451527</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="PLN"><VALUE_COST FMTVAL="173400.00">173 400,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><COMPLEMENTARY_INFORMATION_CONTRACT_AWARD><RELATES_TO_EU_PROJECT_NO/><ADDITIONAL_INFORMATION><P>Zamawiający przewiduje możliwość dokonania najpierw oceny ofert, a następnie zbadania, czy Wykonawca którego oferta została oceniona jako najkorzystniejsza nie podlega wykluczeniu oraz spełnia warunki udziału w postępowaniu. Jeżeli wykonawca, którego oferta została oceniona jako najkorzystniejsza, uchyli się od zawarcia umowy zamawiający zbada, czy nie podlega wykluczeniu oraz czy spełnia warunki udziału w postępowaniu wykonawca, który złożył ofertę najwyżej ocenią spośród pozostałych ofert. (art. 24 aa ust. 1 i 2 Pzp).</P></ADDITIONAL_INFORMATION><PROCEDURES_FOR_APPEAL><APPEAL_PROCEDURE_BODY_RESPONSIBLE><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Krajowa Izba Odwoławcza</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Postępu 17 a</ADDRESS><TOWN>Warszawa</TOWN><POSTAL_CODE>02-676</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>odwolania@uzp.gov.pl</E_MAIL></E_MAILS><PHONE>+48 224527801</PHONE><URL>www.uzp.gov.pl</URL><FAX>+48 224587700</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></APPEAL_PROCEDURE_BODY_RESPONSIBLE><LODGING_OF_APPEALS><LODGING_OF_APPEALS_PRECISION><P>Wykonawcy, a także innemu podmiotowi, jeżeli ma lub miał interes w uzyskaniu danego zamówienia oraz poniósł lub może ponieść szkodę w wyniku naruszenia przez zamawiającego przepisów Ustawy - Prawo zamówień publicznych (Pzp), przysługują środki ochrony prawnej przewidziane cytowaną ustawą.</P><P>Środki ochrony prawnej wobec ogłoszenia o zamówieniu oraz specyfikacji istotnych warunków zamówienia przysługują również organizacjom wpisanym na listę, o której mowa w art. 154 pkt. 5 Pzp.</P><P>Odwołanie przysługuje wyłącznie od niezgodnej z przepisami ustawy czynności zamawiającego podjętej w postępowaniu o udzielenie zamówienia lub zaniechania czynności, do której zamawiający jest zobowiązany na podstawie ustawy.</P><P>Odwołanie powinno wskazywać czynność lub zaniechanie czynności zamawiającego, której zarzuca się niezgodność z przepisami ustawy, zawierać zwięzłe przedstawienie zarzutów, określać żądanie oraz wskazywać okoliczności faktyczne i prawne uzasadniające wniesienie odwołania.</P><P>Odwołanie wnosi się do Prezesa Krajowej Izby Odwoławczej w formie pisemnej lub w postaci elektronicznej podpisane bezpiecznym podpisem elektronicznym weryfikowanym przy pomocy ważnego kwalifikowanego certyfikatu lub równoważnego środka spełniającego wymagania dla tego rodzaju podpisu.</P><P>Odwołujący przesyła kopie odwołania zamawiającemu przed upływem terminu do wniesienia odwołania w taki sposób, aby mógł on zapoznać się z jego treścią przed upływem tego terminu. Domniemywa się, iż Zamawiający mógł zapoznać się z treścią odwołania przed upływem terminu do jego wniesienia, jeżeli przesłanie jego kopii nastąpiło przed upływem terminu do jego wniesienia przy użyciu środków komunikacji elektronicznej.</P><P>Odwołanie wnosi się w terminie 10 dni od dnia przesłania informacji o czynności zamawiającego stanowiącej podstawę jego wniesienia - jeżeli zostały przesłane w sposób określony w art. 180 ust. 5 Pzp zdanie drugie, albo w terminie 15 dni - jeżeli zostały przesłane w inny sposób.</P><P>Odwołanie wobec treści ogłoszenia o zamówieniu oraz wobec postanowień specyfikacji istotnych warunków zamówienia wnosi się w terminie 10 dni od dnia publikacji ogłoszenia w Dzienniku Urzędowym Unii Europejskiej lub zamieszczenia specyfikacji istotnych warunków zamówienia na stronie internetowej. Odwołanie wobec czynności innych niż wyżej wymienione wnosi się w terminie 10 dni od dnia, w którym powzięto lub przy zachowaniu należytej staranności można było powziąć wiadomość o okolicznościach stanowiących podstawę jego wniesienia.</P><P>Na orzeczenie Izby stronom oraz uczestnikom postępowania odwoławczego przysługuje skarga do sądu. Skargę wnosi się do sądu okręgowego właściwego dla siedziby albo miejsca zamieszkania Zamawiającego. Skargę wnosi się za pośrednictwem Prezesa Krajowej Izby Odwoławczej w terminie 7 dni od dnia doręczenia orzeczenia Izby, przesyłając jednocześnie jej odpis przeciwnikowi skargi.</P><P>Złożenie skargi w placówce pocztowej operatora wyznaczonego w rozumieniu ustawy z dnia 23.11.2012 r. - Prawo pocztowe (Dz. U. poz. 1529) jest równoznaczne z jej wniesieniem.</P><P>Szczegółowe zasady wnoszenia środków ochrony prawnej zawarte są w Dziale VI Ustawy - Prawo zamówień publicznych.</P></LODGING_OF_APPEALS_PRECISION></LODGING_OF_APPEALS><LODGING_INFORMATION_FOR_SERVICE><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Krajowa Izba Odwoławcza</OFFICIALNAME></ORGANISATION><ADDRESS>ul. Postępu 17 a</ADDRESS><TOWN>Warszawa</TOWN><POSTAL_CODE>02-676</POSTAL_CODE><COUNTRY VALUE="PL"/><E_MAILS><E_MAIL>odwolania@uzp.gov.pl</E_MAIL></E_MAILS><PHONE>+48 224527801</PHONE><URL>www.uzp.gov.pl</URL><FAX>+48 224587700</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></LODGING_INFORMATION_FOR_SERVICE></PROCEDURES_FOR_APPEAL><NOTICE_DISPATCH_DATE><DAY>17</DAY><MONTH>01</MONTH><YEAR>2018</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_CONTRACT_AWARD></FD_CONTRACT_AWARD></CONTRACT_AWARD></FORM_SECTION></TED_EXPORT>